We are live on
!
Find out more
NAGE
Niagen Bioscience
NAGE
NAGE
169 hedge funds and large institutions have $205M invested in Niagen Bioscience in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 28
13% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 54
4% more funds holding
Funds holding: 162 → 169 (+7)
0.57% more ownership
Funds ownership: 39.8% → 40.37% (+0.57%)
31% less capital invested
Capital invested by funds: $296M → $205M (-$91.1M)
60% less call options, than puts
Call options by funds: $1.23M | Put options by funds: $3.08M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
169
Holders Change
+7
Holders Change %
+4.32%
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
35
Increased
61
Reduced
54
Closed
28
Calls
$1.23M
Puts
$3.08M
Net Calls
-$1.85M
Net Calls Change
-$2.71M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$4.01M |
| 2 |
Morgan Stanley
New York
|
+$2.45M |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
+$2.42M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.5M |
| 5 |
Renaissance Technologies
New York
|
+$1.4M |
